Navigation Links
Fox Chase Cancer Center signs agreement with Life Technologies Corp.
Date:6/13/2011

the initiative is to combine several institutional resources and a multidisciplinary team including scientists and clinicians to evaluate the ways that genomic sequencing can be used in patient management. Fox Chase clinicians will be able to assess a genomic analysis of a patient's tumor compared to their normal tissues. The service will utilize Life Technologies' sequencing and analysis platforms, including the SOLiD system, Ion Torrent semiconductor sequencing, and novel biological information technology systems for analysis of genomic data. It is expected that with appropriate resources and after rigorous testing and validation studies, genome sequencing can become a broadly used diagnostic tool integrated into the standard management of patients with cancer.

"We are proud to power the innovations in cancer care that Fox Chase Cancer Center researchers and clinicians will make," said Greg Lucier, chairman and CEO of Life Technologies. "We expect this model of industry and academic collaboration to demonstrate the effectiveness of sequencing in improving patient care."

The technology will also enable the Cancer Genome Institute at Fox Chase to create a genomic knowledge database. With patient consent, information linking the patient's tumor genotype, the oncologist's recommendation of targeted therapy, and the patient's clinical outcome will be made available to the research and clinical oncology community at large, while protecting the identity of the patient. The database will build on Fox Chase's already substantial Biosample Repository to add a critical additional layer of new knowledge about the genetic information in individual patient tumors.

Fox Chase will also use the database to accelerate the development of new cancer treatments through collaboration with its highly regarded phase 1 clinical trials program, which tests a broad spectrum of novel cancer therapeutics in patients with advanced cancer. The genetic informatio
'/>"/>

Contact: Kristin Hummel
khummel@tierneyagency.com
215-790-4343
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study: Lowering cost doesnt increase hearing aid purchases
2. Fox Chase researchers find that fish oil boosts responses to breast cancer drug tamoxifen
3. Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
4. Fox Chase scientists report interplay between cancer and aging in mice
5. Fox Chase researchers develop a screen for identifying new anticancer drug targets
6. Calorie labeling has no effect on teenagers or parents food purchases
7. Fox Chase researchers uncover new risk factors for brain metastases in breast cancer patients
8. Fox Chase researchers identify risk factors for the spread of breast cancer to lymph nodes
9. Cash is healthier? Credit and debit increase impulsive food purchases
10. CerMedia Completes Purchase of Cell-Pore Principal Assets from NanoDynamics
11. Fox Chase clinical trial tests first of its kind antibody
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 12, 2014 According to new ... market is expected to register a CAGR of ... Browse 71 market data tables and 76 figures ... "C4ISR Market"., http://www.marketsandmarkets.com/Market-Reports/c4isr-market-1315.html , Early buyers ... http://www.marketsandmarkets.com/requestCustomization.asp?id=1315 , The report provides market analysis ...
(Date:7/11/2014)... July 11, 2014 (HealthDay News) -- People with the lowest ... called peripheral artery disease (PAD), a new study suggests. ... blood to the limbs, most often the legs. The condition ... of the arteries throughout the body. People with PAD have ... analyzed data from nearly 6,800 people with PAD who took ...
(Date:7/11/2014)... 11, 2014 The report, “Specialty ... Applications & Geography - 2018,” defines and segments ... with an analysis and forecast of the volumes ... fibers (Para aramids, meta aramids, UHMW Polyethylene, carbon ... PPS fiber, PBI fiber, PBO fiber, and liquid ...
(Date:7/11/2014)... -- In people with sex addiction, pornography affects the ... in drug addicts as they consume drugs, a new ... activity between patients who have compulsive sexual behavior and ... study author Dr. Valerie Voon, of the University of ... Voon,s research involved 19 men with sex addiction ...
(Date:7/11/2014)... Alliance for Cancer Gene Therapy, Inc. ... to cell and gene therapies for cancer – ... organization as Senior Development Officer. , Corday is ... gifts and addressing influential donors. Prior to joining ... NewYork Presbyterian Hospital/Columbia University Medical Center, where he ...
Breaking Medicine News(10 mins):Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 2Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 3Health News:C4ISR Market Estimated to Reach $93.04 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Poor More Prone to Leg Circulation Trouble 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:Brains of Sex Addicts May Be Wired Like Those of Drug Addicts, Study Finds 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 2Health News:Alliance for Cancer Gene Therapy (ACGT) Welcomes Joshua Corday as Senior Development Officer 3
... , , , ... females, a team of Ohio physicians representing the Women,s Dermatologic ... safety education for tennis fans enjoying the Western & Southern ... Saturday, August 15, from 9:00 a.m.-5:00 p.m. Led by board-certified dermatologist ...
... 10 /PRNewswire-Asia/ -- Chindex International, Inc.,("Chindex") (Nasdaq: ... products and services in the People,s Republic of China, ... multi-year distribution,agreements for China with Biotest AG and Cutera ... in Dreieich, Germany (SDAX: BIO3), specializes in,innovative hematology and ...
... , , ANN ARBOR, Mich., ... U.S. health systems based on their hospitals, clinical performance. They are: , , ... , Catholic Healthcare Partners -- Cincinnati, OH , ... HealthEast Care System -- Saint Paul, MN , Henry ...
... PHILADELPHIA, Pennsylvania, August 10 , ... Improve Patient Care, Help,Prevent Costly Mistakes; Hospitals Benefit From ... a world leader in healthcare and medical publishing and ... tool within,Mosby,s Nursing Consult designed to help nurses prevent ...
... ... Enhances Innovative Solutions for Travelers and Individuals , ... Indianapolis, IN (PRWEB) August 10, 2009 ... insurance, today announced it has signed an agreement with Eldorado Computing, Inc. (Eldorado) ...
... ... balance, confidence and quality of life. , ... Hamilton, AL (PRWEB) Jeanne Crace, 70, who has five daughters, ... Parkinson,s disease. , , , , ,Parkinson,s Disease remains a mystery of medical ...
Cached Medicine News:Health News:Ohio Dermatologists to Help Tennis Community Get Into the Swing of Sun Safety 2Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 2Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 3Health News:Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products 4Health News:Thomson Reuters Research Identifies Top U.S. Health Systems 2Health News:Thomson Reuters Research Identifies Top U.S. Health Systems 3Health News:Nurses to Benefit From New CMS Never Events Resource Area on Mosby's Nursing Consult 2Health News:Nurses to Benefit From New CMS Never Events Resource Area on Mosby's Nursing Consult 3Health News:Nurses to Benefit From New CMS Never Events Resource Area on Mosby's Nursing Consult 4Health News:HCC Medical Insurance Services Selects Eldorado's Innovative Claims & Benefits Platform 2Health News:Exploring Newly Found Freedom with the GaitAid for Parkinson's Disease 2Health News:Exploring Newly Found Freedom with the GaitAid for Parkinson's Disease 3
(Date:7/10/2014)... , July 10, 2014  Decision Resources Group ... infectious disease (ID) specialists are willing to prescribe ... (oritavancin) for use as OPAT, approximately two-thirds of ... agents to their hospital inpatients. However, our findings ... patients are initiated on OPAT following hospital discharge, ...
(Date:7/10/2014)... Decision Resources Group finds that over half ... and Drug Administration,s (FDA) approval of Vifor Fresenius Medical ... approved by the FDA in November 2013 for the ... on dialysis. Other key findings from the ... : , Bundling: ...
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients want ... a recent online survey* sponsored by Mission Pharmacal Company. ... National Osteoporosis Foundation online support community, revealed that 74 ... that comes in a form other than a pill ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3
... Varian Medical Systems (NYSE: VAR ) ... U.S. Customs and Border Protection (CBP) for multiple IntellX® cargo ... company,s largest single order for Varian,s IntellX gantry systems. The ... vehicles for both border security and manifest verification purposes. ...
... 2011 DURECT Corporation (Nasdaq: DRRX ) ... (FDA) has accepted the resubmission of the New Drug ... KG ) and the PDUFA goal date ... ) REMOXY, based on DURECT,s ORADUR® technology, ...
Cached Medicine Technology:Varian Medical Systems' Security and Inspection Products Group Receives Largest Single Order for IntellX Systems 2REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 2REMOXY® New Drug Application Accepted by the FDA with PDUFA Goal Date of June 23, 2011 3
They employ Lea Symbols. Contrast levels are the same at 25%, 10%, 5%, 2.5% and 1.25%. Each offers a different set of Lea Symbols to guard against memorization. Also uses recording forms (P/N 215400)...
Symbol 10' Test Chart 10/100 to 10/10 size. 9" x 14"....
Wilbrandt-binkhorst irrigating cannula....
Binkhorst, length 35 mm....
Medicine Products: